Data from French trial should inform treatment decisions in the majority of lung cancer patients aged 70 and up.
Mary Beth Nierengarten
Advertisement
Articles by Mary Beth Nierengarten
Advertisement
Latest Updated Articles
Doublet Chemo Proves Superior to Single-agent Therapy in Older Patients with Advanced Non-small-cell Lung CancerPublished: August 9th 2010 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
2
Crawford Strunk, MD, on Integrating Gene Therapy into Clinical Care for Sickle Cell Disease
3
Janna Minehart, MD, on Hematology-Oncology Immunotherapy Highlights at ASH 2025
4
Integrating Gene Therapy into Clinical Care for Sickle Cell Disease
5
